Form 4: Astera Labs CEO Jitendra Mohan Sells Shares Under 10b5-1 Plan

Astera Labs CEO Jitendra Mohan sold a total of 2,304 shares of common stock at a weighted average price of $100.0079 per share, under a pre-arranged 10b5-1 trading plan.

Summary

• Jitendra Mohan, CEO of Astera Labs, sold 2,304 shares of common stock on November 11, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024.
• The shares were sold at a weighted average price of $100.0079 per share.
• The transactions involved multiple sales, with 2,100 shares sold at $100.0000 and 202 shares at $100.0900.
• The shares were sold from various trusts where Mr. Mohan is a trustee, including a living trust and several estate planning trusts.
• Mr. Mohan disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing for a stock sale under a pre-arranged plan, which is neither positive nor negative. It's a neutral event.

Risks

• The sale of shares by the CEO, even under a pre-arranged plan, could be perceived negatively by some investors.
• The market may react to the sale, potentially impacting the stock price.

Management Comments

• The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest.

Industry Context

Executive stock sales are a common occurrence, especially under pre-arranged trading plans like Rule 10b5-1, which allows insiders to sell shares without being accused of trading on non-public information. This is a routine filing and does not indicate any specific change in the company's performance or outlook.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a standard practice for executives at publicly traded companies to manage their personal finances and avoid accusations of insider trading.
• The volume of shares sold is relatively small compared to the total shares held by the CEO, suggesting this is a routine transaction rather than a significant divestment.

Stakeholder Impact

• The stock sale may have a minor impact on shareholder sentiment, but it is unlikely to have a significant effect given the pre-arranged nature of the transaction.

Key Dates

Keywords

Astera Labs, Jitendra Mohan, stock sale, Rule 10b5-1, insider trading, SEC Form 4, executive transaction